Abstract |
Chronic hepatitis B and C virus infections have been characterized by the pathophysiological features with a high incidence of progression to cirrhosis and development of hepatocellular carcinoma. The viral persistence produced by escape mutations from virus-specific cytotoxic T lymphocytes (CTL) response may lead to upregulation of delayed-type hypersensitivity immune response, which causes hepatic tissue damage through non specific macrophage activation and CTL response and promotes pathogenesis of hepatic fibrosis. In a preliminary clinical study, a novel metalloendopeptidase-F ( MEP-F) has been shown to be effective in the treatment of patients with either chronic hepatitis B or C infection. Oral administration of MEP-F resulted in a significant reduction of the serum levels of HBs antigen and HCV RNA and improvement in the liver function abnormalities. However, the mechanism of action of MEP-F is not yet well understood. There are accumulating evidences showing an important role of alpha 2-macroglobulin-proteinase complexes in regulatory mechanisms of immune response and repairing within impaired and inflammatory tissues. In this article, reviewing the pharmacological and biological properties of alpha 2-macroglobulin-proteinase complexes, the mechanism of anti-viral effect of MEP-F is examined based on the clinical findings. It is indicated that alpha 2-macroglobulin-MEP-F complexes may induce macrophage/Kuppfer cell activation and proliferation through binding their receptors on the cells and activating signaling cascades, which enhance both anti-viral specific and nonspecific immune responses. alpha 2-Macroglobulin-MEP-F complexes may also augment cellular immunity and hepatic regeneration by neutralizing the immunosuppressive and fibrogenic activities of transforming growth factor-beta.
|
Authors | S Fujisaki, T Fujisaki, J Yoshida, Y Fujisaki, M Mitani, M Nakamura, N Otake |
Journal | The Japanese journal of antibiotics
(Jpn J Antibiot)
Vol. 53
Issue 3
Pg. 135-56
(Mar 2000)
ISSN: 0368-2781 [Print] Japan |
PMID | 10834146
(Publication Type: English Abstract, Journal Article, Review)
|
Chemical References |
- Cytokines
- Low Density Lipoprotein Receptor-Related Protein-1
- Receptors, Immunologic
- Transforming Growth Factor beta
- alpha-Macroglobulins
- Metalloendopeptidases
- metalloendopeptidase F
|
Topics |
- Animals
- Cytokines
(metabolism, physiology)
- Hepatitis B, Chronic
(immunology, therapy)
- Hepatitis C, Chronic
(immunology, therapy)
- Humans
- Liver
(metabolism, physiology)
- Liver Regeneration
- Low Density Lipoprotein Receptor-Related Protein-1
- Macrophages
(immunology)
- Metalloendopeptidases
(metabolism, pharmacology, therapeutic use)
- Receptors, Immunologic
(metabolism, physiology)
- T-Lymphocytes, Cytotoxic
(immunology)
- Transforming Growth Factor beta
(antagonists & inhibitors)
- alpha-Macroglobulins
(metabolism, physiology)
|